Expert Review Of Gastroenterology & Hepatology

Journal Title：Expert Review Of Gastroenterology & Hepatology

The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.

全世界胃肠道疾病给健康和经济带来了巨大的负担，因此需要高度关注病因、流行病学、预防、诊断、治疗和新疗法的开发。到上个世纪末，我们已经看到了巨大的进步，无论是在疾病可视化技术方面，还是在胃溃疡等领域的治愈疗法方面，首先是 H2 拮抗剂的出现，然后是质子泵抑制剂的出现 - 这些都是医学进步如何极大地造福患者的明显例子。然而，专家们仍面临着来自各种病因的多种疾病的持续挑战。

Expert Review Of Gastroenterology & Hepatology创刊于2007年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖GASTROENTEROLOGY & HEPATOLOGY全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 较慢,6-12周 ，影响因子指数3.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。